European Journal of Cancer Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients Gabriela G.F. van der Schoot, Nico-Derk L. Westerink, Sjoukje Lubberts, Janine Nuver, Nynke Zwart, Annemiek M.E. Walenkamp, Johan B. Wempe, Coby Meijer, Jourik A. Gietema European Journal of Cancer Volume 59, Pages 134-141 (May 2016) DOI: 10.1016/j.ejca.2016.02.013 Copyright © 2016 Elsevier Ltd Terms and Conditions
Fig. 1 Overall survival of testicular cancer patients treated with bleomycin–cisplatin combination chemotherapy according to HFE H63D variant status. European Journal of Cancer 2016 59, 134-141DOI: (10.1016/j.ejca.2016.02.013) Copyright © 2016 Elsevier Ltd Terms and Conditions
Fig. 2 Overall survival of testicular cancer patients treated with bleomycin–cisplatin combination chemotherapy according to combined HFE H63D and C282Y variant status. European Journal of Cancer 2016 59, 134-141DOI: (10.1016/j.ejca.2016.02.013) Copyright © 2016 Elsevier Ltd Terms and Conditions
Fig. A1 Overall survival of testicular cancer patients treated with bleomycin–cisplatin combination chemotherapy according to HFE C282Y variant status. European Journal of Cancer 2016 59, 134-141DOI: (10.1016/j.ejca.2016.02.013) Copyright © 2016 Elsevier Ltd Terms and Conditions